A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

I8H-MC-BDCM -

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes that have already been treated with basal insulin.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Type 2 Diabetes
What the trial is testing?
Insulin Degludec, LY3209590
Could I receive a Placebo?
No
Enrollment Goal
399
Trial Dates
Nov 15, 2018 - Feb 18, 2020
How long will I be in the trial?
The study will last about 39 weeks and may include up to 23 visits.
Trial Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.